Latex beads (0.8-,um diameter; Difco Laboratories) were coated with fibronectin, fibrinogen, collagen type 1, or denatured collagen (gelatin) 
The adherence of bacterial pathogens to the epithelial cell surfaces of various host tissues is the initial step in the pathogenesis of many infections (2) . Binding to various components of the extracellular matrix such as fibronectin (Fn), collagens (Cn), laminin, and vitronectin may allow wound pathogens to colonize damaged tissues (9, 30) .
Gram-positive bacterial pathogens cause a wide variety of pyogenic infections commonly associated with tissue trauma and surgical wounds. Staphylococcus aureus and group A streptococci seem to colonize traumatized connective tissues and blood clots in wounded tissues by binding to fibrinogen (Fg), fibrin, Fn, and various tissue Cn (12, 25, 28, 31) . The binding of S. aureus, group A streptococci, and tissue-invasive pyelonephritogenic Escherichia coli to laminin, a specific basal membrane protein, has also been reported (14, 24) . Treponema pallidum and certain parasites have also been shown to bind to connective-tissue proteins (27) . The binding of type II Cn to S. aureus, coagulasenegative staphylococci, and group A, C, and G streptococci has been described recently (3, 23) . One fibronectin-binding protein (FnBP) was isolated from S. aureus (4, 7, 20) , and the gene of strain 8325-4 has been cloned and expressed in E. coli (6) . The specific attachment of S. aureus to immobilized Fn coated on glass, plastic, and polystyrene surfaces has also been reported (13, 16, 18, 22) .
The properties of binding of bacterial pathogens to serum and connective-tissue proteins are being investigated at several laboratories. A commonly used method is a binding assay with '25I-labeled proteins (8, 26) . This A total of 187 S. aureus strains isolated from various clinical sources at the routine diagnostic laboratory, Lund Hospital, Lund, Sweden, were also tested by PAA and Staphaurex.
Preparation of standard latex reagents. One milliliter of latex particle suspension (bead diameter of 0.8 ,um) was mixed with 3 ml of 0.17 M glycine-NaOH (gly) buffer (pH 8.2) and centrifuged at 4,500 x g for 5 min (Sorvall RC-5B), and the pellet was resuspended in 3 ml of the same buffer.
Highly purified protein (100 itg; porcine plasma Fn for the Fn reagent [Fn-PAA], Cn type I and II for the Cn reagent [Cn-PAA], and bovine Fg for the Fg reagent [Fg-PAA]) was added, and the mixtures were kept at 30°C for 12 h on a horizontal shaker at 50 rotations per min. The mixtures were centrifuged at 9,200 x g for 5 min at 20°C, and the supernatants were discarded. The pellet was resuspended in 2 ml of the gly buffer containing 0.01% ovalbumin and 0.01% Merthiolate and kept at 4°C for 12 h.
Gel-PAA was prepared as described above with a slight modification. Gel (200 ,ug) was added to 0.2 ml of gly buffer, dissolved by warming at 45°C for 10 min in a water bath, and then added to the latex suspension. Latex particles were also coated with ovalbumin to check nonspecific agglutination reactions. The reagents were thoroughly suspended before use.
PAA. Strains were grown on various agar media for 24 h. Bacterial colonies were suspended and washed once in 0.02 M potassium phosphate (Pp) buffer (pH 6.8). Bacterial cells were resuspended in the same buffer to approximately 1010 cells per ml and immediately tested for PAA reactivity.
Latex reagent (1 drop; 20 ,ul) was placed on a glass slide, and an equal volume of bacterial cell suspension was added. The 2 drops were gently mixed, and the agglutination reaction was read after 2 min. The reactions were scored from Cn types I to V from various tissue sources, purchased from Sigma, were not suitable for the preparation of Cn-PAA. Vitrogen was suitable for the preparation of Cn-PAA and was comparable with Cn types I and II purified by the method of Miller and Rhodes (17) .
Incubation temperature has a pronounced influence on the quality of the PAA reagent during preparation. Protein adsorption on the particles was low at 4°C, whereas at 37°C, the reagent often autoaggregated. An incubation temperature of 30°C with gentle shaking at 50 rpm for 12 h was found to be optimum for coating latex particles with Fn, Cn, Gel, and Fg.
Clinical application of PAA. Standardized PAAs were evaluated by using 187 S. aureus clinical isolates positive for Staphaurex ( Table 3 ). The (18, 26) . The emerging problem of coagulase-negative staphylococcus infections is of equal clinical importance as that of S. aureus infection. Thus, the comparison and, later, the combination of the PAA with the Staphaurex test indicate the pathological relevance of serum protein binding to staphylococci in general.
A commonly practiced method for the screening of cell surface properties is a binding assay with '25M-labeled proteins (8, 20, 23, 26) . This technique is not available to most laboratories because of the lack of instrumentation and expertise. Although the method is sensitive, it is time consuming and involves radiation hazards during routine testing of clinical isolates for the property to bind serum and connective-tissue proteins. 125I labeling of proteins can interfere with biological activity by loading tyrosine residues (19) . Moreover, the instability of Fn in buffer solutions and its susceptibility to proteases, precipitation, and denaturation during freezing and thawing further complicate the use of assays with '25I-labeled protein (19) .
The development of the present PAA test is based on the fact that certain bacterial pathogens have serum proteinbinding ligands on the cell surface. The physicochemical forces in the adsorption of serum glycoproteins to latex above pH 7.5 are mainly hydrophobic and not charge interactions. With an appropriate protein concentration and buffer, protein configurations are less affected (1) .
Comparative studies of the PAA with the assay with 1251-labeled proteins showed a a good correlation between the two methods (Fig. 2 ). An Fn-PAA +/-or -reaction corresponded to a median value of 11.5% relative to the binding to strain (4, 7, 20, 23) . Our data also suggested the influence of growth culture medium and the molarity and pH of the cell suspension buffer on the PAA and the Staphaurex test.
The preliminary clinical evaluation showed the potential of these newly developed PAAs. These tests are extremely rapid and sensitive for the routine screening of large quantities of clinical material for serum and connective-tissue protein binding. The PAA can be used as a presumptive test before the binding assay with 1'25-labeled protein and the blocking quantitative assay are performed. To cite an example, the strong Cn-PAA reactivity (instant + + +) of TSS strains is an interesting presumptive finding. Later, in the binding assay with '25M-labeled Cn, TSS strains showed a binding value approximately three times higher than that of laboratory strain Cowan 1, a result comparable with that of the PAA.
In conclusion, simple PAAs have been developed for the rapid screening of the Fn-, Gel-, Cn-, and Fg-binding properties of staphylococci. During the development and evaluation of these new PAAs, the Staphaurex test was used for control and comparison. The PAA reagents were highly sensitive, specific, and stable and are thus recommended for the rapid screening of clinical isolates for binding properties. Furthermore, these assays could be very useful for screening mutants and gene libraries for Fn-, Cn-, and Fg-binding proteins. We are now further evaluating these assays on a large number of coagulase-negative staphylococci, E. coli, and group A, C, and G streptococci isolated from various human and animal infections.
